Caxton Associates (UK)’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
VCM
VPM
Caxton Associates (UK)'s LH Position: Q1 2026 in Review
Caxton Associates (UK) reduced its Labcorp (LH) stake by 29% in Q1 2026, selling an estimated $538K and leaving 4,845 shares worth $1.29M. The position accounts for 0.03% of the portfolio, ranked #319.
Caxton Associates (UK) first reported a position in LH in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Caxton Associates (UK) held 4,845 shares of Labcorp worth $1.29M as of Q1 2026.
- Caxton Associates (UK) sold 1,986 Labcorp shares in Q1 2026, an estimated $538K.
- Labcorp made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #319 holding.
- Caxton Associates (UK) first reported a position in Labcorp in Q1 2025 and has held it in 5 quarters since.
- Caxton Associates (UK)'s Labcorp position peaked at $2.58M in Q1 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.